等待開盤 09-17 09:30:00 美东时间
-0.013
-3.18%
今日重点评级关注:HC Wainwright & Co.:上调Cardiff Oncology评级至"买入",目标价9美元;古根海姆:维持Inventiva"买入"评级,目标价从11美元升至14美元
09-16 16:10
Noble Capital Markets analyst Robert LeBoyer maintains Geovax Labs (NASDAQ:GOVX) with a Outperform and maintains $10 price target.
09-15 22:42
The latest update is out from GeoVax Labs ( ($GOVX) ). GeoVax Labs, Inc., a cli...
09-11 05:02
Geovax Labs (NASDAQ:GOVX) reported quarterly losses of $(0.97) per share which beat the analyst consensus estimate of $(2.88) by 66.32 percent. This is a 88.9 percent increase over losses of $(8.74) per share from the same period last year.
07-28 04:37
https://www.state.gov/releases/office-of-the-spokesperson/2026/06/ebola-response-update-june-5-2026/
06-06 02:24
GeoVax shares gain after the company highlighted its MVA vaccine platform's potential against Ebola and Marburg threats.
05-21 02:07
GeoVax Labs ($GOVX), Roboai ($AIIO), and Sunshine Biopharma ($SBFM) are the thr...
05-20 00:21
GOVX stock pulls back premarket after an 80% rally as GeoVax Labs announces a $3M private placement, sparking dilution fears.
05-19 21:29
Gainers Sunshine Biopharma (NASDAQ:SBFM) stock moved upwards by 635.6% to $2.0...
05-18 20:05
Liveramp Holdings Inc (NYSE: RAMP) rose in pre-market trading after being acquired by Publicis for $2.2 billion. Other gainers include SBFM, NXXT, GOVX, CREG, PMI, ZDAI, GCTS, CMPS, and DXYZ. BTM, EDBL, PIII, ARTL, and HCWB were among the losers.
05-18 17:38